
Andropause and low testosterone are often used as if they mean the same thing. They are closely related, but they are not interchangeable, and the difference matters for how a doctor thinks about diagnosis and treatment. This guide explains what each term means, where they overlap, and where the distinction matters in practice.
Andropause and low testosterone are often used as if they mean the same thing. They are closely related, but they are not interchangeable, and the difference matters for how a doctor thinks about diagnosis and treatment. This guide explains what each term means, where they overlap, and where the distinction matters in practice.
For a broader picture of low testosterone in Singapore, see our complete guide.
Low testosterone is the broader clinical condition: a man's testosterone level is meaningfully below the normal range, and he has symptoms consistent with that. It can affect men at almost any adult age, and it has many possible causes.
Andropause is a specific subtype: the gradual, age-related decline in testosterone that becomes clinically significant in some older men. Clinically it is often called late-onset hypogonadism (LOH). Andropause is a form of low testosterone, but not all low testosterone is andropause.
Think of it this way. "Heart disease" is a broad clinical category; "coronary artery disease" is one specific form. The relationship between low testosterone (broad) and andropause (specific subtype affecting older men due to ageing) is similar.

From about age 40 onwards, men's total testosterone tends to decline by roughly 1% per year. For most men, this decline is gradual and unremarkable; testosterone stays within the normal range for decades. For a meaningful minority, the decline is steep enough — or combines with other factors — to push testosterone below the normal range and produce symptoms.
When this happens, doctors describe it as andropause or late-onset hypogonadism. Estimates of how many men over 45 are affected vary widely (depending on the threshold applied), but the picture is broadly that 20–40% of men over 45 have testosterone levels considered clinically low. In Singapore, a health screening study of 1,000 men found around 26% had clinically low testosterone.
The features that distinguish andropause specifically:
Low testosterone in younger men, or in older men where the cause is specific rather than age-related, looks different. Common scenarios include:
A 30-year-old with low testosterone is not going through andropause. A 60-year-old with low testosterone might be, or might have a specific other cause. The label only describes the broad mechanism, not the underlying biology.
For most men reading this, the practical question is: my testosterone is low, what do I do? The answer is broadly similar whether the underlying picture is andropause or some other cause: address reversible factors, discuss treatment options, make decisions based on symptoms and clinical judgement. But the label does shape a few things.
Investigation depth. A 40-year-old gradually accumulating symptoms over years typically gets a different workup than a 32-year-old with a suddenly low result. The latter is more likely to need imaging or genetic investigation to find a specific cause.
Treatment expectations. Andropause is, in part, a gradual age-related process. Treatment can help meaningfully with symptoms, but it does not reverse ageing more broadly. Framing the conversation around symptom relief, not anti-ageing, sets honest expectations.
Fertility considerations. A younger man with low testosterone often has fertility on the radar. Testosterone replacement therapy can suppress sperm production, which is a much bigger issue for a man who plans to have children soon than for a 65-year-old whose family is complete.
Monitoring. The cardiovascular, prostate, and other monitoring considerations are broadly similar across causes, but the priorities shift with age.
The decision is usually fairly straightforward and based on history rather than a single test. Your doctor will ask: how old are you, how gradually did symptoms develop, are there obvious triggers (medication, illness, weight change), and what does the rest of the picture look like (LH, FSH, prolactin, thyroid).
In Singapore, the common clinical convention is to use "andropause" or "late-onset hypogonadism" when speaking to older men with age-related symptoms, and to use the broader term "low testosterone" or "hypogonadism" when speaking about the condition in general. The terms are not mutually exclusive; an older man can be told he has both.
"Male menopause" is a popular term used in everyday conversation to describe the same broad phenomenon as andropause. Most doctors prefer "andropause" or "late-onset hypogonadism" because "male menopause" implies a direct equivalent to female menopause, which it isn't — the changes are slower, less universal, and biologically different.
There is no single starting age. Testosterone begins its gradual decline around 40, but most men do not develop clinically significant symptoms until their 50s or 60s, if at all. Some men in their 40s do experience symptoms.
Technically no — by most definitions, andropause requires both age-related testosterone decline and clinical symptoms. A man with symptoms but a normal testosterone level usually has another cause, and shouldn't be labelled andropause.
Broadly yes — the treatment categories are the same. The trade-offs and conversations differ based on age, fertility plans, and other health factors.
If you are wondering whether what you are experiencing is andropause, low testosterone, or something else entirely, the only way to find out is to talk to a doctor. Book a confidential consultation with a Singapore-licensed doctor on Noah.


Articles on Noah are for informational purposes only and do not replace medical advice from a qualified doctor. To consult on Noah, click here. Noah's editorial standards are described on our editorial standards page.
Wu FCW, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. NEJM. 2010;363(2):123–135.
Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018;103(5):1715–1744.
Singapore Medical Association. Understanding Male Andropause. SMA News, 2025. (Link)